Outset Medical Inc header image

Outset Medical Inc

OM

Equity

ISIN null / Valor 56717137

NASDAQ (2026-02-20)
USD 3.53%

Outset Medical Inc
UMushroom community rating:

star star star star star
3.80 5 votes No rating yet
NegativeNeutralPositive

About company

Outset Medical Inc. is a healthcare company that specializes in innovative solutions for the nephrology market, focusing on improving the care model for acute renal failure both in intensive and sub-acute hospital settings. The company is known for its commitment to applying industrial continuous quality improvement concepts to nephrology, aiming to transform patient care through technology and innovation. Outset Medical's approach includes the development of medical devices and services that cater to the specific needs of patients and healthcare providers in the field of dialysis. With a team that includes experts like Dr. Alvarez, who serves as the Chief Technology and Innovation Advisor and brings a wealth of experience from both clinical practice and the pharmaceutical and device industries, Outset Medical positions itself at the forefront of nephrology care. The company offers differentiated service agreements tailored to meet the unique needs and capabilities of each customer, indicating a flexible and patient-centric approach to healthcare solutions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-75.5%1Y
-99.1%3Y
-99.6%5Y

Performance

115%1Y
127%3Y
109%5Y

Volatility

Market cap

65 M

Market cap (USD)

Daily traded volume (Shares)

241,665

Daily traded volume (Shares)

1 day high/low

1.21 / 1.09

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.80

5 votes
Performance:
starstarstarstarstar
3.50
Innovation:
starstarstarstarstar
4.25
Society:
starstarstarstarstar
4.50
Nature:
starstarstarstarstar
3.50
Melanie S
Switzerland, 30 Mar 2025
star star star star star
noch nie von gehört, klingt aber spannend
Caterina F
Switzerland, 28 Mar 2025
star star star star star
Interesting
Mahmut Yasar
Switzerland, 28 Mar 2025
star star star star star
Super Anlage

EQUITIES OF THE SAME SECTOR

Staar Surgical Co
Staar Surgical Co Staar Surgical Co Valor: 972813
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.67%USD 17.76
Tecan Group Ltd.
Tecan Group Ltd. Tecan Group Ltd. Valor: 1210019
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.83%CHF 137.90
Evotec SE
Evotec SE Evotec SE Valor: 3979578
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.12%USD 3.53
Galenica Ltd.
Galenica Ltd. Galenica Ltd. Valor: 36067446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.46%CHF 101.30
Idorsia Ltd
Idorsia Ltd Idorsia Ltd Valor: 36346343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.40%CHF 3.69
Medtronic PLC
Medtronic PLC Medtronic PLC Valor: 25187155
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.74%USD 96.86
Baxter International Inc
Baxter International Inc Baxter International Inc Valor: 911702
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.12%USD 21.58
Bio-Rad Laboratories Inc
Bio-Rad Laboratories Inc Bio-Rad Laboratories Inc Valor: 912793
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.22%USD 271.30
Omnicell Inc
Omnicell Inc Omnicell Inc Valor: 1275961
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.22%USD 40.26
ImmunityBio Inc
ImmunityBio Inc ImmunityBio Inc Valor: 110468647
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.05%USD 8.70